Digital Content 
NEWS #PharmaBuzz
30 Aug 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/08/30/2734160/0/en/Eagle-Pharmaceuticals-to-Present-BYFAVO-remimazolam-for-Injection-Abstract-at-Prestigious-Society-for-Neuroscience-in-Anesthesiology-and-Critical-Care-SNACC-Conference.html
01 May 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/05/01/2658143/0/en/Eagle-Pharmaceuticals-Granted-Unique-J-Code-for-Byfavo-remimazolam-for-injection-from-CMS.html
16 Feb 2023
// EMA
https://www.ema.europa.eu/en/documents/overview/byfavo-epar-medicine-overview_en.pdf
28 Jan 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/01/28/2165464/0/en/Acacia-Pharma-Launches-BYFAVO-remimazolam-in-the-United-States-for-Procedural-Sedation-in-Adults-Undergoing-Medical-Procedures-Lasting-30-Minutes-or-Less.html
15 Jul 2020
// GLOBENEWLSWIRE
https://www.globenewswire.com/news-release/2020/07/15/2062294/0/en/Acacia-Pharma-Assigned-US-License-for-BYFAVO-remimazolam-by-Cosmo-Pharmaceuticals-NV.html
02 Jul 2020
// PRESS RELEASE
https://www.cosmopharma.com/news-and-media/press-releases-and-company-news/2020/200702#:~:text=Video%20Gallery-,Cosmo%20Pharmaceuticals%20Announces%20US%20FDA%20Approval%20of%20BYFAVO%E2%84%A2%20(remimazolam,and%20Maintenance%20of%20Procedural%20Sedation&text=As%20a%20result%20of%20the,company%20will%20increase%20to%2024.05%25.
Share 